Martin Meltzer






Schwartz AM, Shankar MB, Kugeler KJ, Max RJ, Hinckley AF, Meltzer MI, Nelson CA. (2020). Epidemiology and cost of Lyme disease-related hospitalizations among patients with employer-sponsored health insurance-United States, 2005-2014. Zoonoses and public health, 67(4)

Carias C, Hills SL, Kahn EB, Adhikari BB, Fischer M, Meltzer MI. (2020). Comparative economic analysis of strategies for Japanese encephalitis vaccination of U.S. travelers. Vaccine

Bambery Z, Cassell CH, Bunnell RE, Roy K, Ahmed Z, Payne RL, Meltzer MI. (2018). Impact of a Hypothetical Infectious Disease Outbreak on US Exports and Export-Based Jobs. Health security, 16(1)

Fischer LS, Santibanez S, Hatchett RJ, Jernigan DB, Meyers LA, Thorpe PG, Meltzer MI. (2016). CDC Grand Rounds: Modeling and Public Health Decision-Making. MMWR. Morbidity and mortality weekly report, 65(48)

Skelton AG, Meltzer MI. (2017). 20 Years of Public Health Economics and Decision Sciences at the US Centers for Disease Control and Prevention: The CDC Steven M. Teutsch Prevention Effectiveness Fellowship, 1995-2015. Journal of public health management and practice : JPHMP, 23(4)

Carias C, Reed C, Kim IK, Foppa IM, Biggerstaff M, Meltzer MI, Finelli L, Swerdlow DL. (2015). Net Costs Due to Seasonal Influenza Vaccination--United States, 2005-2009. PloS one, 10(7)

Washington ML, Meltzer ML, . (2015). Effectiveness of Ebola treatment units and community care centers - Liberia, September 23-October 31, 2014. MMWR. Morbidity and mortality weekly report, 64(3)

Rainisch G, Shankar M, Wellman M, Merlin T, Meltzer MI. (2015). Regional spread of Ebola virus, West Africa, 2014. Emerging infectious diseases, 21(3)

Biggerstaff M, Reed C, Swerdlow DL, Gambhir M, Graitcer S, Finelli L, Borse RH, Rasmussen SA, Meltzer MI, Bridges CB. (2015). Estimating the potential effects of a vaccine program against an emerging influenza pandemic--United States. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (60 Suppl 1)

Rainisch G, Asher J, George D, Clay M, Smith TL, Kosmos C, Shankar M, Washington ML, Gambhir M, Atkins C, Hatchett R, Lant T, Meltzer MI. (2015). Estimating Ebola Treatment Needs, United States. Emerging infectious diseases, 21(7)

Reed C, Chaves SS, Daily Kirley P, Emerson R, Aragon D, Hancock EB, Butler L, Baumbach J, Hollick G, Bennett NM, Laidler MR, Thomas A, Meltzer MI, Finelli L. (2015). Estimating influenza disease burden from population-based surveillance data in the United States. PloS one, 10(3)

Meltzer MI, Atkins CY, Santibanez S, Knust B, Petersen BW, Ervin ED, Nichol ST, Damon IK, Washington ML, . (2014). Estimating the future number of cases in the Ebola epidemic--Liberia and Sierra Leone, 2014-2015. MMWR supplements, 63(3)

Kostova D, Reed C, Finelli L, Cheng PY, Gargiullo PM, Shay DK, Singleton JA, Meltzer MI, Lu PJ, Bresee JS. (2013). Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011. PloS one, 8(6)

Adachi K, Coleman MS, Khan N, Jentes ES, Arguin P, Rao SR, LaRocque RC, Sotir MJ, Brunette G, Ryan ET, Meltzer MI, . (2014). Economics of malaria prevention in US travelers to West Africa. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 58(1)

Borse RH, Shrestha SS, Fiore AE, Atkins CY, Singleton JA, Furlow C, Meltzer MI. (2013). Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009-2010. Emerging infectious diseases, 19(3)

Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng PY, Bandaranayake D, Breiman RF, Brooks WA, Buchy P, Feikin DR, Fowler KB, Gordon A, Hien NT, Horby P, Huang QS, Katz MA, Krishnan A, Lal R, Montgomery JM, Mølbak K, Pebody R, Presanis AM, Razuri H, Steens A, Tinoco YO, Wallinga J, Yu H, Vong S, Bresee J, Widdowson MA. (2012). Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. The Lancet. Infectious diseases, 12(9)

Reed C, Meltzer MI, Finelli L, Fiore A. (2012). Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine, 30(11)

Shrestha SS, Sosin DM, Meltzer MI. (2012). Planning for baseline medical care needs of a displaced population after a disaster. Disaster medicine and public health preparedness, 6(4)

Prosser LA, Lavelle TA, Fiore AE, Bridges CB, Reed C, Jain S, Dunham KM, Meltzer MI. (2011). Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States. PLoS One, 6(7)

Shrestha SS, Swerdlow DL, Borse RH, Prabhu VS, Finelli L, Atkins CY, Owusu-Edusei K, Bell B, Mead PS, Biggerstaff M, Brammer L, Davidson H, Jernigan D, Jhung MA, Kamimoto LA, Merlin TL, Nowell M, Redd SC, Reed C, Schuchat A, Meltzer MI. (2011). Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (52 Suppl 1)

Atkins CY, Patel A, Taylor TH Jr., Biggerstaff M, Merlin TL, Dulin SM, Erickson BA, Borse RH, Hunkler R, Meltzer MI. (2011). Estimating effect of antiviral drug use during pandemic (H1N1) 2009 outbreak, United States. Emerging infectious diseases, 17(9)

Borse RH, Behravesh CB, Dumanovsky T, Zucker JR, Swerdlow D, Edelson P, Choe-Castillo J, Meltzer MI. (2011). Closing schools in response to the 2009 pandemic influenza A H1N1 virus in New York City: economic impact on households. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (52 Suppl 1)

Somda ZC, Perry HN, Messonnier NR, Djingarey MH, Ki SO, Meltzer MI. (2010). Modeling the cost-effectiveness of the integrated disease surveillance and response (IDSR) system: meningitis in Burkina Faso. PLoS One, 5(9)

Shrestha SS, Wallace GS, Meltzer MI. (2010). Modeling the national pediatric vaccine stockpile: supply shortages, health impacts and cost consequences. Vaccine, 28(38)

Gift TL, Palekar RS, Sodha SV, Kent CK, Fagan RP, Archer WR, Edelson PJ, Marchbanks T, Bhattarai A, Swerdlow D, Ostroff S, Meltzer MI, . (2010). Household effects of school closure during pandemic (H1N1) 2009, Pennsylvania, USA. Emerging infectious diseases, 16(8)

Reed C, Angulo FJ, Swerdlow DL, Lipsitch M, Meltzer MI, Jernigan D, Finelli L. (2009). Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerging infectious diseases, 15(12)

Dhankhar P, Vaidya SA, Fishbien DB, Meltzer MI. (2008). Cost effectiveness of rabies post exposure prophylaxis in the United States. Vaccine, 26(33)

Washington ML, Mason J, Meltzer MI. (2005). Maxi-Vac: planning mass smallpox vaccination clinics. Journal of public health management and practice : JPHMP, 11(6)

Kaufmann AF, Pesik NT, Meltzer MI. (2005). Syndromic surveillance in bioterrorist attacks. Emerging infectious diseases, 11(9)

Roy K, Wang SA, Meltzer MI. (2005). Optimizing treatment of antimicrobial-resistant Neisseria gonorrhoeae. Emerging infectious diseases, 11(8)

Shepard DS, Suaya JA, Halstead SB, Nathan MB, Gubler DJ, Mahoney RT, Wang DN, Meltzer MI. (2004). Cost-effectiveness of a pediatric dengue vaccine. Vaccine, 22(9-10)

Scott RD 2nd., Gregg E, Meltzer MI. (2004). Collecting data to assess SARS interventions. Emerging infectious diseases, 10(7)

Meltzer MI, Bridges CB. (2003). Economic analysis of influenza vaccination and treatment. Annals of internal medicine, 138(7)